Cas 1179336-51-6,(S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one

1179336-51-6

Post Buying Request

Basic information

Product Name: (S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one
Synonyms: (S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one
CAS NO:1179336-51-6
Molecular Formula:
Molecular Weight: 340.338
EINECS: N/A
Product Categories: N/A
Mol File: 1179336-51-6.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one(CAS DataBase Reference)
NIST Chemistry Reference: (S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one(1179336-51-6)
EPA Substance Registry System: (S)-8-(2-azido-1-hydroxyethyl)-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one(1179336-51-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1179336-51-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1179336-51-6 Suppliers

Recommended suppliersmore

1179336-51-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1179336-51-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,9,3,3 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1179336-51:
(9*1)+(8*1)+(7*7)+(6*9)+(5*3)+(4*3)+(3*6)+(2*5)+(1*1)=176
176 % 10 = 6
So 1179336-51-6 is a valid CAS Registry Number.

1179336-51-6Upstream product

1179336-51-6Downstream Products

1179336-51-6Relevant articles and documents

Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists

Weichert, Dietmar,Stanek, Markus,Hübner, Harald,Gmeiner, Peter

, p. 2641 - 2653 (2016/06/08)

Aiming to discover dual-acting β2 adrenergic/dopamine D2 receptor ligands, a structure-guided approach for the evolution of GPCR agonists that address multiple targets was elaborated. Starting from GPCR crystal structures, we describ

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1179336-51-6